These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 9921882)

  • 1. Fluctuating penile erection related with levodopa therapy.
    Jiménez-Jiménez FJ; Tallón-Barranco A; Cabrera-Valdivia F; Gasalla T; Ortí-Pareja M; Zurdo M
    Neurology; 1999 Jan; 52(1):210. PubMed ID: 9921882
    [No Abstract]   [Full Text] [Related]  

  • 2. Penile erections and hypersexuality induced by pergolide treatment in advanced, fluctuating Parkinson's disease.
    Kanovský P; Bares M; Pohanka M; Rektor I
    J Neurol; 2002 Jan; 249(1):112-4. PubMed ID: 11954860
    [No Abstract]   [Full Text] [Related]  

  • 3. Case 1, 1996: rapidly progressive parkinsonism, incontinence, impotency, and levodopa-induced moaning in a patient with multiple myeloma.
    Fahn S; Brin MF; Dwork AJ; Weiner WJ; Goetz CG; Rajput AH
    Mov Disord; 1996 May; 11(3):298-310. PubMed ID: 8723148
    [No Abstract]   [Full Text] [Related]  

  • 4. Levodopa toxicity in Parkinson disease.
    Lessell S
    Arch Neurol; 2000 Sep; 57(9):1382. PubMed ID: 10987914
    [No Abstract]   [Full Text] [Related]  

  • 5. [Levodopa+selegiline combination and increase of risk of mortality in the treatment of Parkinson disease].
    Dubois B; Montastruc JL
    Rev Neurol (Paris); 1996 Feb; 152(2):103-5. PubMed ID: 8761616
    [No Abstract]   [Full Text] [Related]  

  • 6. Parkinson disease: the controversy of levodopa toxicity in Parkinson disease.
    Zesiewicz TA
    Nat Rev Neurol; 2011 Dec; 8(1):8-10. PubMed ID: 22198404
    [No Abstract]   [Full Text] [Related]  

  • 7. Welcome news about levodopa, but uncertainty remains.
    Fahn S
    Ann Neurol; 1998 May; 43(5):551-4. PubMed ID: 9585348
    [No Abstract]   [Full Text] [Related]  

  • 8. Mydriasis in a Parkinson disease patient on low-dose carbidopa/levodopa.
    Burdick DJ; Griffith A; Agarwal P
    Mov Disord; 2013 Mar; 28(3):295. PubMed ID: 23526432
    [No Abstract]   [Full Text] [Related]  

  • 9. Weighing the neurological complexities of long-term levodopa use.
    Sacks O
    Arch Neurol; 2000 Oct; 57(10):1531. PubMed ID: 11030811
    [No Abstract]   [Full Text] [Related]  

  • 10. Ropinirole as compared with levodopa in Parkinson's disease.
    Hiner BC; Earnhart M
    N Engl J Med; 2000 Sep; 343(12):884; author reply 885. PubMed ID: 11001684
    [No Abstract]   [Full Text] [Related]  

  • 11. Is chronic levodopa therapy associated with distal symmetric polyneuropathy in Parkinson's disease?
    Shahrizaila N; Mahamad UA; Yap AC; Choo YM; Marras C; Lim SY
    Parkinsonism Relat Disord; 2013 Mar; 19(3):391-3. PubMed ID: 23146348
    [No Abstract]   [Full Text] [Related]  

  • 12. Freezing of Gait and Its Levodopa Paradox.
    Nonnekes J; Bereau M; Bloem BR
    JAMA Neurol; 2020 Mar; 77(3):287-288. PubMed ID: 31841600
    [No Abstract]   [Full Text] [Related]  

  • 13. [Long-term complications of treatment with levodopa].
    Castro García A; Sesar Ignacio A
    Neurologia; 1998; 13 Suppl 1():41-8. PubMed ID: 9859685
    [No Abstract]   [Full Text] [Related]  

  • 14. Intravenous levodopa in hallucinating PD patients.
    Friedman JH
    Neurology; 1999 Jan; 52(1):219-20. PubMed ID: 9921891
    [No Abstract]   [Full Text] [Related]  

  • 15. Zotepine in levodopa-induced Psychosis.
    Spieker S; Stetter F; Klockgether T
    Mov Disord; 1995 Nov; 10(6):795-7. PubMed ID: 8750001
    [No Abstract]   [Full Text] [Related]  

  • 16. What would Dr. James Parkinson think today? parcelling out the circuitry of levodopa-induced dyskinesias.
    Kordower JH
    Mov Disord; 2017 Apr; 32(4):483-484. PubMed ID: 28425143
    [No Abstract]   [Full Text] [Related]  

  • 17. Letter regarding "Heterotopic ossification following distal radius fractures in a patient with Parkinson disease treated with levodopa-carbidopa".
    Namazi H
    J Hand Surg Am; 2013 Sep; 38(9):1867-8. PubMed ID: 23981426
    [No Abstract]   [Full Text] [Related]  

  • 18. Serpentine tongue: A rare manifestation following initiation of levodopa therapy in a patient with Parkinson's disease.
    Prashantha DK; Pal PK
    Parkinsonism Relat Disord; 2009 Nov; 15(9):718-9. PubMed ID: 19157953
    [No Abstract]   [Full Text] [Related]  

  • 19. Levodopa--toxic or neuroprotective?
    Weiner WJ
    Nat Clin Pract Neurol; 2006 Oct; 2(10):518-9. PubMed ID: 16990820
    [No Abstract]   [Full Text] [Related]  

  • 20. Current controversies: levodopa in the treatment of Parkinson's disease.
    Sharma JC; Vassallo M; Ross IN
    Mov Disord; 2005 May; 20(5):642-3; author reply 643-4. PubMed ID: 15732129
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.